Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1974 1
1975 1
1976 2
1978 4
1979 3
1980 2
1981 7
1982 5
1983 3
1984 6
1985 9
1986 7
1987 10
1988 9
1989 13
1990 11
1991 7
1992 21
1993 26
1994 15
1995 20
1996 24
1997 15
1998 21
1999 31
2000 30
2001 43
2002 34
2003 37
2004 42
2005 47
2006 64
2007 60
2008 84
2009 69
2010 79
2011 98
2012 104
2013 96
2014 106
2015 127
2016 152
2017 141
2018 138
2019 146
2020 138
2021 149
2022 124
2023 125
2024 92

Text availability

Article attribute

Article type

Publication date

Search Results

2,284 results

Results by year

Filters applied: . Clear all
Page 1
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG. Pan H, et al. N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830. N Engl J Med. 2017. PMID: 29117498 Free PMC article.
The risk of death from breast cancer was similarly dependent on TN status, but the risk of contralateral breast cancer was not. ...During the study period from 5 to 20 years, the absolute risk of distant recurrence among pat …
The risk of death from breast cancer was similarly dependent on TN status, but the risk of contralateral …
Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE, Lostumbo L, Wallace J, Ko H. Carbine NE, et al. Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4. Cochrane Database Syst Rev. 2018. PMID: 29620792 Free PMC article. Review.
BACKGROUND: Recent progress in understanding the genetic basis of breast cancer and widely publicized reports of celebrities undergoing risk-reducing mastectomy (RRM) have increased interest in RRM as a method of preventing breast cancer. ...SEL …
BACKGROUND: Recent progress in understanding the genetic basis of breast cancer and widely publicized reports of celebrities u …
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators. Kunkler IH, et al. Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Lancet Oncol. 2015. PMID: 25637340 Clinical Trial.
BACKGROUND: For most older women with early breast cancer, standard treatment after breast-conserving surgery is adjuvant whole-breast radiotherapy and adjuvant endocrine treatment. ...FUNDING: Chief Scientist Office (Scottish Government), Breast …
BACKGROUND: For most older women with early breast cancer, standard treatment after breast-conserving surgery is adjuva …
The risk of contralateral breast cancer: a SEER-based analysis.
Giannakeas V, Lim DW, Narod SA. Giannakeas V, et al. Br J Cancer. 2021 Aug;125(4):601-610. doi: 10.1038/s41416-021-01417-7. Epub 2021 May 26. Br J Cancer. 2021. PMID: 34040177 Free PMC article.
BACKGROUND: We sought to estimate the annual risk and 25-year cumulative risk of contralateral breast cancer among women with stage 0-III unilateral breast cancer. ...The annual risk of contralateral breast …
BACKGROUND: We sought to estimate the annual risk and 25-year cumulative risk of contralateral breast cancer …
Contralateral breast cancer risk.
Unnithan J, Macklis RM. Unnithan J, et al. Radiother Oncol. 2001 Sep;60(3):239-46. doi: 10.1016/s0167-8140(01)00369-3. Radiother Oncol. 2001. PMID: 11514003 Review.
The use of breast-conserving treatment approaches for breast cancer has now become a standard option for early stage disease. ...One concern that has been raised is the question of radiation- related contralateral breast cancer after b …
The use of breast-conserving treatment approaches for breast cancer has now become a standard option for early stage di …
Smoking, Radiation Therapy, and Contralateral Breast Cancer Risk in Young Women.
Reiner AS, Watt GP, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Smith SA, Liang X, Woods M, Shore R, Malone KE, Bernstein L; WECARE Study Collaborative Group; Bernstein JL. Reiner AS, et al. J Natl Cancer Inst. 2022 Apr 11;114(4):631-634. doi: 10.1093/jnci/djab047. J Natl Cancer Inst. 2022. PMID: 33779721 Free PMC article.
Evidence is mounting that cigarette smoking contributes to second primary contralateral breast cancer (CBC) risk. Whether radiation therapy (RT) interacts with smoking to modify this risk is unknown. ...There was no evidence that RT further incr …
Evidence is mounting that cigarette smoking contributes to second primary contralateral breast cancer (CBC) risk …
Contralateral risk reducing mastectomy in patients with sporadic breast cancer. Benefits and hazards.
Boccardo C, Gentilini O. Boccardo C, et al. Eur J Surg Oncol. 2016 Jul;42(7):913-8. doi: 10.1016/j.ejso.2016.04.054. Epub 2016 May 3. Eur J Surg Oncol. 2016. PMID: 27189832 Review.
Nevertheless, women with breast cancer are more frequently requesting a radical approach comprising contralateral mastectomy even if they do not have a demonstrated increased genetic risk. In this paper we reviewed the main reasons patients ask for agg …
Nevertheless, women with breast cancer are more frequently requesting a radical approach comprising contralateral maste …
CBCRisk-Black: a personalized contralateral breast cancer risk prediction model for black women.
Sajal IH, Chowdhury M, Wang T, Euhus D, Choudhary PK, Biswas S. Sajal IH, et al. Breast Cancer Res Treat. 2022 Jul;194(1):179-186. doi: 10.1007/s10549-022-06612-5. Epub 2022 May 13. Breast Cancer Res Treat. 2022. PMID: 35562619 Free PMC article.
PURPOSE: Black breast cancer (BC) survivors have a higher risk of developing contralateral breast cancer (CBC) than Whites. ...METHODS: We propose an absolute risk prediction model, CBCRisk-Black, specifically for Black BC patients …
PURPOSE: Black breast cancer (BC) survivors have a higher risk of developing contralateral breast canc …
Use of beta-blockers and risk of contralateral breast cancer.
Gottschau M, Bens A, Friis S, Cronin-Fenton D, Aalborg GL, Jensen MB, Ejlertsen B, Kroman N, Mellemkjaer L. Gottschau M, et al. Int J Cancer. 2022 May 15;150(10):1619-1626. doi: 10.1002/ijc.33923. Epub 2022 Jan 25. Int J Cancer. 2022. PMID: 34985760
Beta-blockers have shown antineoplastic effects in laboratory studies but epidemiologic evidence in relation to contralateral breast cancer (CBC) is sparse. We investigated postdiagnosis beta-blocker use and risk of CBC in a cohort of 52 723 women with …
Beta-blockers have shown antineoplastic effects in laboratory studies but epidemiologic evidence in relation to contralateral brea …
Bilateral Mastectomy and Breast Cancer Mortality.
Giannakeas V, Lim DW, Narod SA. Giannakeas V, et al. JAMA Oncol. 2024 Sep 1;10(9):1228-1236. doi: 10.1001/jamaoncol.2024.2212. JAMA Oncol. 2024. PMID: 39052262
The 20-year risk of contralateral breast cancer was 6.9% (95% CI, 6.1%-7.9%) in the lumpectomy-unilateral mastectomy group. ...CONCLUSIONS AND RELEVANCE: This cohort study indicates that the risk of dying of breast cancer increases …
The 20-year risk of contralateral breast cancer was 6.9% (95% CI, 6.1%-7.9%) in the lumpectomy-unilateral mastec …
2,284 results